menu
    • menu

    Company profile for Assia Chemical Industries Ltd

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Teva-Tech is the fastest growing manufacturing facility of TAPI. Most of the new chemically synthesized products produced by TAPI are manufactured at this location, or will be in the future. Many dedicated, high volume manufacturing areas can be found at Teva-Tech. The leading products produced at Teva-Tech include Gabapentin, Furosemide, Azithromycin, Clarithromycin, Venlafaxine. In addition, Teva-Tech produces certain niche ...
    Teva-Tech is the fastest growing manufacturing facility of TAPI. Most of the new chemically synthesized products produced by TAPI are manufactured at this location, or will be in the future. Many dedicated, high volume manufacturing areas can be found at Teva-Tech. The leading products produced at Teva-Tech include Gabapentin, Furosemide, Azithromycin, Clarithromycin, Venlafaxine. In addition, Teva-Tech produces certain niche products, using novel technologies that are difficult to develop. Examples of these products include peptides such as Desmopressin and Vitamin D derivatives such as Calcitriol, Alpha D3 and Calcipotriene.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Assia Chemical Industries LtdIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Neot-Hovav Eco-Industrial Park, Emek Sara P.O Box 2049 Be'er Sheva 8412316
    Telephone
    Telephone
    +972-39255519
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.teva.co.il/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Teva Pharma's Generics Tiopronin Receives Approval in US
    Teva Pharma's Generics Tiopronin Receives Approval in US

    22 Jul 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216456

    FDA
    22 Jul 2024
    Share Share
    U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
    U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents

    23 Apr 2024

    // Blake Brittain REUTERS

    https://www.reuters.com/legal/us-supreme-court-rejects-vanda-pharmaceuticals-case-over-sleep-drug-patents-2024-04-22/

    Blake Brittain REUTERS
    23 Apr 2024
    Share Share
    Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient
    Teva, like Hikma, accuses Amarin of hoarding Vascepa ingredient

    30 Mar 2024

    // Fraiser Kansteiner FIERCE PHARMA

    https://www.fiercepharma.com/pharma/teva-follows-suit-after-hikmas-2023-complaint-arguing-amarin-locked-drug-ingredient-supply

    Fraiser Kansteiner FIERCE PHARMA
    30 Mar 2024
    Share Share
    Teva reports revenue increase, says it will sell API business
    Teva reports revenue increase, says it will sell API business

    01 Feb 2024

    // Kevin Dunleavy FIERCE PHARMA

    https://www.fiercepharma.com/pharma/continuing-its-transformation-teva-confirms-intent-sell-api-business

    Kevin Dunleavy FIERCE PHARMA
    01 Feb 2024
    Share Share
    Accused of complicity in opioid crisis, Teva launches nasal spray
    Accused of complicity in opioid crisis, Teva launches nasal spray

    25 Dec 2021

    // TIMESOFISRAEL

    https://www.timesofisrael.com/accused-of-complicity-in-opioid-crisis-teva-launches-nasal-spray-to-treat-overdose/

    TIMESOFISRAEL
    25 Dec 2021
    Share Share
    Teva's Ajovy can't find solid win against oral migraine rivals
    Teva's Ajovy can't find solid win against oral migraine rivals

    09 Sep 2021

    // N. H. Dunn FIERCEPHARMA

    https://www.fiercepharma.com/pharma/teva-trailing-cgrp-rivals-migraine-can-t-find-a-win-ajovy-analysis-versus-biohaven-and

    N. H. Dunn FIERCEPHARMA
    09 Sep 2021
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Aripiprazole

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Aripiprazole

    Israel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 228MF10057

    Registrant's Address : Neot-Hovav Eco-Industrial Park, Be\'er Sheva 8412316, Israel

    Initial Date of Registration : 2016-02-18

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 63415-0085

    Start Marketing Date : 2019-08-19

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (100kg/100kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Sam-O Pharmaceutical Co., Ltd.

    Registration Date : 2021-07-11

    Registration Number : 20210711-209-J-1033

    Manufacturer Name : Asia Chemical Industries Ltd.

    Manufacturer Address : Neot-Hovav Eco-Industrial Park, Emek Sara, PO Box 2049, Be'er Sheva 8412316 Israel

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Candesartan Cilexetil

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Candesartan Cilexetil

    Israel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 224MF10142

    Registrant's Address : Neot-Hovav Eco-Industrial Park, Emek Sara P. O. Box 2049 Be\'er Sheva 8412316, Israel

    Initial Date of Registration : 2012-07-31

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Cilostazol

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Cilostazol

    Israel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 225MF10130

    Registrant's Address : Neot-Hovav Eco-Industrial Park, Emek Sara P. O. Box 2049 Be\'er Sheva 8412316, Israel

    Initial Date of Registration : 2013-07-09

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 63415-0034

    Start Marketing Date : 2017-11-27

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (100kg/100kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Sam-O Pharmaceutical Co., Ltd.

    Registration Date : 2005-09-30

    Registration Number : 20050930-28-C-18-10

    Manufacturer Name : Asia Chemical Industries Ltd. Teva-Tech Site

    Manufacturer Address : Neot-Hovav Eco-Industrial Park, Emek Sara, PO Box, 2049 Be'er Sheva 8412316, Israel

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Duloxetine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Duloxetine Hydrochloride

    Israel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 302MF10024

    Registrant's Address : Neot-Hovav Eco-Industrial Park, Be\'er Sheva 8412316, Israel

    Initial Date of Registration : 2020-02-06

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Sam-O Pharmaceutical Co., Ltd.

    Registration Date : 2010-09-30

    Registration Number : 711-6-ND

    Manufacturer Name : Asia Chemical Industries Ltd.

    Manufacturer Address : Neot-Hovav Eco-Industrial Park, Emek Sara, POB 2049, Be'er Sheva, 8412316, Israel

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Lansoprazole

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Lansoprazole

    Israel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 219MF10026

    Registrant's Address : Neot-Hovav Eco-Industrial Park, Emek Sara P. O. Box 2049 Be\'er Sheva 8412316, Israel

    Initial Date of Registration : 2007-02-05

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 63415-0060

    Start Marketing Date : 2017-12-07

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (100kg/100kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Sam-O Pharmaceutical Co., Ltd.

    Registration Date : 2005-09-30

    Registration Number : 20050930-3-B-200-07

    Manufacturer Name : Asia Chemical Industries Ltd. (Teva-Tech site)

    Manufacturer Address : Neot-Hovav Eco-Industrial Park, Emek Sara, POB 2049, Be'er Sheva, 8412316, Israel

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Levofloxacin

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Levofloxacin

    Israel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 218MF10535

    Registrant's Address : Neot-Hovav Eco-Industrial Park, Be\'er Sheva 8412316, Israel

    Initial Date of Registration : 2006-06-01

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 63415-0056

    Start Marketing Date : 2020-04-30

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (100kg/100kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Maxacalcitol

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Maxacalcitol

    Israel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 226MF10176

    Registrant's Address : Neot-Hovav Eco-Industrial Park, Be\'er Sheva 8412316, Israel

    Initial Date of Registration : 2014-09-01

    Latest Date of Registration :

    EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Modafinil

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Modafinil

    Israel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 227MF10270

    Registrant's Address : Neot-Hovav Eco-Industrial Park, Be\'er Sheva 8412316, Israel

    Initial Date of Registration : 2015-11-19

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 63415-0036

    Start Marketing Date : 2019-08-13

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (100kg/100kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : JW Pharmaceutical Co., Ltd.

    Registration Date : 2023-05-11

    Registration Number : 20230511-209-J-1490

    Manufacturer Name : Assia Chemical Industries Ltd. (Teva Tech site)

    Manufacturer Address : Neot-Hovav Eco-Ind. Park, Emek Sara, P.OB. 2049, Be'er Sheva, 8412316, Israel

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Telmisartan

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Telmisartan

    Israel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 228MF10045

    Registrant's Address : Neot-Hovav Eco-Industrial Park, Emek Sara P. O. Box 2049 Be\'er Sheva 8412316, Israel

    Initial Date of Registration : 2016-02-08

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : Sam-O Pharmaceutical Co., Ltd.

    Registration Date : 2018-03-12

    Registration Number : 20180312-209-J-80

    Manufacturer Name : Assia Chemical Industries Ltd.Teva-Tech site

    Manufacturer Address : Neot-Hovav Eco-Industrial Park, Emek Sara, PO Box 2049, Be'er Sheva 8412316, Israel

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Zoledronic Acid

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Zoledronic Acid

    Israel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF CEP/COS JDMF arrow-down
    ✖

    Registration Number : 225MF10045

    Registrant's Address : Neot-Hovav Eco-Industrial Park, Be\'er Sheva 8412316, Israel

    Initial Date of Registration : 2013-03-05

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 63415-0532

    Start Marketing Date : 2023-07-12

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Announces Results from 3-Year Study Assessing the Safety and Tolerability of AUSTEDO® (deutetrabenazine) Tablets for the Treatment of Chorea Assoc...

    Details:

    AUSTEDO (deutetrabenazine) is the first and only vesicular monoamine transporter 2 (VMAT2) inhibitor approved by the U.S. Food and Drug Administration for the treatment of tardive dyskinesia (TD) in adults and for the treatment of chorea associated with Huntington’s disease.


    Lead Product(s): Deutetrabenazine

    Therapeutic Area: Musculoskeletal Brand Name: Austedo

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable October 18, 2022

    blank

    01

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Deutetrabenazine

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Teva Announces Results from 3-Year Study Assessing the Safety and Tolerability of AUSTEDO® (deute...

    Details : AUSTEDO (deutetrabenazine) is the first and only vesicular monoamine transporter 2 (VMAT2) inhibitor approved by the U.S. Food and Drug Administration for the treatment of tardive dyskinesia (TD) in adults and for the treatment of chorea associated with ...

    Product Name : Austedo

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    October 18, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir® Digihaler® (albuterol sulfate) Inhalation Powder at the European Respirator...

    Details:

    Study evaluated the effect of ProAir Digihaler System on asthma control versus standard of care as measured by Asthma Control Test, and explored use of the ProAir Digihaler System to help support patient-physician interactions for asthma management versus standard of care.


    Lead Product(s): Salbutamol Sulphate

    Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: ProAir Digihaler

    Study Phase: Approved FDFProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable August 29, 2022

    blank

    02

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Salbutamol Sulphate

    Therapeutic Area : Pulmonary/Respiratory Diseases

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Teva to Present First Data Set from the CONNECT1 Clinical Trial on ProAir® Digihaler® (albuterol...

    Details : Study evaluated the effect of ProAir Digihaler System on asthma control versus standard of care as measured by Asthma Control Test, and explored use of the ProAir Digihaler System to help support patient-physician interactions for asthma management versu...

    Product Name : ProAir Digihaler

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    August 29, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MedinCell’s Partner Teva Provides Additional Information Regarding the New Drug Application for mdc-IRM

    Details:

    mdc-IRM, (risperidone) extended-release injectable suspension for the treatment of patients with schizophrenia (Teva codename: TV-46000), is the most advanced investigational product based on MedinCell’s BEPO® technology.


    Lead Product(s): Risperidone

    Therapeutic Area: Psychiatry/Psychology Brand Name: mdc-IRM

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Recipient: Teva Pharmaceutical Industries

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable May 03, 2022

    blank

    03

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Risperidone

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Phase III

    Recipient : Teva Pharmaceutical Industries

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    MedinCell’s Partner Teva Provides Additional Information Regarding the New Drug Application for ...

    Details : mdc-IRM, (risperidone) extended-release injectable suspension for the treatment of patients with schizophrenia (Teva codename: TV-46000), is the most advanced investigational product based on MedinCell’s BEPO® technology.

    Product Name : mdc-IRM

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    May 03, 2022

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MedinCell Provides an Update on Its Product Portfolio, Following the FDA Acceptance of New Drug Application for the Product mdc-IRM

    Details:

    MedinCell and Teva announced yesterday the FDA acceptance of the New Drug Application for mdc-IRM for patients with schizophrenia.


    Lead Product(s): Risperidone

    Therapeutic Area: Psychiatry/Psychology Brand Name: mdc-IRM

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Recipient: Teva Pharmaceutical Industries

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable September 01, 2021

    blank

    04

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Risperidone

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Phase III

    Recipient : Teva Pharmaceutical Industries

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    MedinCell Provides an Update on Its Product Portfolio, Following the FDA Acceptance of New Drug Ap...

    Details : MedinCell and Teva announced yesterday the FDA acceptance of the New Drug Application for mdc-IRM for patients with schizophrenia.

    Product Name : mdc-IRM

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    September 01, 2021

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ironwood Pharmaceuticals Announces Agreement with Teva Involving LINZESS® (linaclotide) 72 mcg Dosage Strength

    Details:

    Ironwood and AbbVie have reached an agreement with Teva Pharmaceuticals providing a license to Teva's abbreviated new drug application seeking approval to market a generic version of 72 mcg LINZESS® (linaclotide) prior to the expiration of the companies' applicable patents.


    Lead Product(s): Linaclotide

    Therapeutic Area: Gastroenterology Brand Name: Linzess

    Study Phase: Approved FDFProduct Type: Peptide, Unconjugated

    Recipient: Ironwood Pharmaceuticals

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement May 26, 2021

    blank

    05

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Linaclotide

    Therapeutic Area : Gastroenterology

    Highest Development Status : Approved FDF

    Recipient : Ironwood Pharmaceuticals

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Ironwood Pharmaceuticals Announces Agreement with Teva Involving LINZESS® (linaclotide) 72 mcg Do...

    Details : Ironwood and AbbVie have reached an agreement with Teva Pharmaceuticals providing a license to Teva's abbreviated new drug application seeking approval to market a generic version of 72 mcg LINZESS® (linaclotide) prior to the expiration of the companies...

    Product Name : Linzess

    Product Type : Peptide, Unconjugated

    Upfront Cash : Undisclosed

    May 26, 2021

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Alvotech Announces that the U.S. FDA and EMA Have Accepted Regulatory Submissions for AVT02, a Proposed Biosimilar to Humira® (Adalimumab)

    Details:

    AVT02 is a proposed biosimilar of HUMIRA® (adalimumab) with high concentration (100mg/mL) dosage forms that are expected to be beneficial to patients and to be differentiated from most biosimilar competitors, while matching the newest dosage forms of the reference product.


    Lead Product(s): Adalimumab

    Therapeutic Area: Dermatology Brand Name: Simlandi

    Study Phase: Phase IIIProduct Type: Antibody, Unconjugated

    Recipient: Alvotech

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable November 19, 2020

    blank

    06

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Adalimumab

    Therapeutic Area : Dermatology

    Highest Development Status : Phase III

    Recipient : Alvotech

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Alvotech Announces that the U.S. FDA and EMA Have Accepted Regulatory Submissions for AVT02, a Pro...

    Details : AVT02 is a proposed biosimilar of HUMIRA® (adalimumab) with high concentration (100mg/mL) dosage forms that are expected to be beneficial to patients and to be differentiated from most biosimilar competitors, while matching the newest dosage forms of th...

    Product Name : Simlandi

    Product Type : Antibody, Unconjugated

    Upfront Cash : Inapplicable

    November 19, 2020

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market

    Details:

    Under this partnership agreement, Alvotech will be responsible for the development, registration and supply of the biosimilars, while Teva will be exclusively commercializing the products in the U.S.


    Lead Product(s): Undisclosed

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Undisclosed

    Recipient: Alvotech

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership August 05, 2020

    blank

    07

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed

    Assia Chemical Industries Ltd

    Israel
    arrow
    AMWC Asia-TDAC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Undisclosed

    Therapeutic Area : Oncology

    Highest Development Status : Undisclosed

    Recipient : Alvotech

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market

    Details : Under this partnership agreement, Alvotech will be responsible for the development, registration and supply of the biosimilars, while Teva will be exclusively commercializing the products in the U.S.

    Product Name : Undisclosed

    Product Type : Undisclosed

    Upfront Cash : Undisclosed

    August 05, 2020

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Orange Book

    read-more
    read-more

    01

    Brand Name : AMLODIPINE BESYLATE

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Brand Name : AMLODIPINE BESYLATE

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    AMLODIPINE BESYLATE

    Assia Chemical Industries Ltd

    Dosage Form : TABLET; ORAL

    Proprietary Name : AMLODIPINE BESYLATE

    Dosage Strength : EQ 2.5MG BASE

    Approval Date : 2026-01-22

    Application Number : 219686

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : AMLODIPINE BESYLATE

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Brand Name : AMLODIPINE BESYLATE

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    AMLODIPINE BESYLATE

    Assia Chemical Industries Ltd

    Dosage Form : TABLET; ORAL

    Proprietary Name : AMLODIPINE BESYLATE

    Dosage Strength : EQ 5MG BASE

    Approval Date : 2026-01-22

    Application Number : 219686

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : AMLODIPINE BESYLATE

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Brand Name : AMLODIPINE BESYLATE

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    AMLODIPINE BESYLATE

    Assia Chemical Industries Ltd

    Dosage Form : TABLET; ORAL

    Proprietary Name : AMLODIPINE BESYLATE

    Dosage Strength : EQ 10MG BASE

    Approval Date : 2026-01-22

    Application Number : 219686

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : ATORVASTATIN CALCIUM

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Brand Name : ATORVASTATIN CALCIUM

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ATORVASTATIN CALCIUM

    Assia Chemical Industries Ltd

    Dosage Form : TABLET; ORAL

    Proprietary Name : ATORVASTATIN CALCIUM

    Dosage Strength : EQ 10MG BASE

    Approval Date : 2025-11-13

    Application Number : 220276

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : ATORVASTATIN CALCIUM

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Brand Name : ATORVASTATIN CALCIUM

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ATORVASTATIN CALCIUM

    Assia Chemical Industries Ltd

    Dosage Form : TABLET; ORAL

    Proprietary Name : ATORVASTATIN CALCIUM

    Dosage Strength : EQ 20MG BASE

    Approval Date : 2025-11-13

    Application Number : 220276

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : ATORVASTATIN CALCIUM

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Brand Name : ATORVASTATIN CALCIUM

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ATORVASTATIN CALCIUM

    Assia Chemical Industries Ltd

    Dosage Form : TABLET; ORAL

    Proprietary Name : ATORVASTATIN CALCIUM

    Dosage Strength : EQ 40MG BASE

    Approval Date : 2025-11-13

    Application Number : 220276

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : ATORVASTATIN CALCIUM

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Brand Name : ATORVASTATIN CALCIUM

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ATORVASTATIN CALCIUM

    Assia Chemical Industries Ltd

    Dosage Form : TABLET; ORAL

    Proprietary Name : ATORVASTATIN CALCIUM

    Dosage Strength : EQ 80MG BASE

    Approval Date : 2025-11-13

    Application Number : 220276

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : CABOZANTINIB

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Brand Name : CABOZANTINIB

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    CABOZANTINIB

    Assia Chemical Industries Ltd

    Dosage Form : TABLET; ORAL

    Proprietary Name : CABOZANTINIB

    Dosage Strength : 20MG

    Approval Date :

    Application Number : 215942

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : CABOZANTINIB

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Brand Name : CABOZANTINIB

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    CABOZANTINIB

    Assia Chemical Industries Ltd

    Dosage Form : TABLET; ORAL

    Proprietary Name : CABOZANTINIB

    Dosage Strength : 40MG

    Approval Date :

    Application Number : 215942

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : CABOZANTINIB

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow

    Brand Name : CABOZANTINIB

    Israel
    AMWC Asia-TDAC
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD :

    TE Code :

    CABOZANTINIB

    Assia Chemical Industries Ltd

    Dosage Form : TABLET; ORAL

    Proprietary Name : CABOZANTINIB

    Dosage Strength : 60MG

    Approval Date :

    Application Number : 215942

    RX/OTC/DISCN :

    RLD :

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Assia Chemical Industries Ltd and get a quotation

    Assia Chemical Industries Ltd is a supplier offers 72 products (APIs, Excipients or Intermediates).

    Find Aripiprazole bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Candesartan Cilexetil bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Cilostazol bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Duloxetine Hydrochloride bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Lansoprazole bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Levofloxacin bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Losartan Potassium bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Maxacalcitol bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Modafinil bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Nateglinide bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Paroxetine Hydrochloride bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Risperidone bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Telmisartan bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Zoledronic Acid bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Zolpidem Tartrate bulk with JDMF offered by Assia Chemical Industries Ltd

    Find ST-ID2498 bulk with JDMF offered by Assia Chemical Industries Ltd

    Find Diclofenac Sodium bulk offered by Assia Chemical Industries Ltd

    Find Nitrofurantoin bulk offered by Assia Chemical Industries Ltd

    Find Nitrofurazone bulk offered by Assia Chemical Industries Ltd

    Find Triamterene bulk offered by Assia Chemical Industries Ltd

    Find FACILITIES AND PERSONNEL IN PETAH TIKVA, ISRAEL bulk offered by Assia Chemical Industries Ltd

    Find Acyclovir bulk offered by Assia Chemical Industries Ltd

    Find Alendronate Sodium bulk offered by Assia Chemical Industries Ltd

    Find Apixaban bulk offered by Assia Chemical Industries Ltd

    Find Aripiprazole bulk offered by Assia Chemical Industries Ltd

    Find Atorvastatin bulk offered by Assia Chemical Industries Ltd

    Find Calcipotriol bulk offered by Assia Chemical Industries Ltd

    Find Calcitriol bulk offered by Assia Chemical Industries Ltd

    Find Carbidopa bulk offered by Assia Chemical Industries Ltd

    Find Carvedilol bulk offered by Assia Chemical Industries Ltd

    Find Carvedilol Phosphate bulk offered by Assia Chemical Industries Ltd

    Find Cinacalcet Hydrochloride bulk offered by Assia Chemical Industries Ltd

    Find Clarithromycin bulk offered by Assia Chemical Industries Ltd

    Find Clopidogrel bulk offered by Assia Chemical Industries Ltd

    Find Darifenacin Hydrobromide bulk offered by Assia Chemical Industries Ltd

    Find Desmopressin Acetate bulk offered by Assia Chemical Industries Ltd

    Find Dorzolamide Hydrochloride bulk offered by Assia Chemical Industries Ltd

    Find Doxcercalciferol bulk offered by Assia Chemical Industries Ltd

    Find Exenatide bulk offered by Assia Chemical Industries Ltd

    Find Fluoxetine Hydrochloride bulk offered by Assia Chemical Industries Ltd

    Find Furosemide bulk offered by Assia Chemical Industries Ltd

    Find Gabapentin bulk offered by Assia Chemical Industries Ltd

    Find Ibandronate Sodium bulk offered by Assia Chemical Industries Ltd

    Find Ibrutinib bulk offered by Assia Chemical Industries Ltd

    Find Icatibant Acetate bulk offered by Assia Chemical Industries Ltd

    Find Irbesartan bulk offered by Assia Chemical Industries Ltd

    Find Lamotrigine bulk offered by Assia Chemical Industries Ltd

    Find Latanoprostene Bunod bulk offered by Assia Chemical Industries Ltd

    Find Linagliptin bulk offered by Assia Chemical Industries Ltd

    Find Losartan Potassium bulk offered by Assia Chemical Industries Ltd

    Find Metoprolol Succinate bulk offered by Assia Chemical Industries Ltd

    Find Metoprolol Tartrate bulk offered by Assia Chemical Industries Ltd

    Find Nefazodone Hydrochloride bulk offered by Assia Chemical Industries Ltd

    Find Octreotide Acetate bulk offered by Assia Chemical Industries Ltd

    Find Olmesartan Medoxomil bulk offered by Assia Chemical Industries Ltd

    Find Paricalcitol bulk offered by Assia Chemical Industries Ltd

    Find Pregabalin bulk offered by Assia Chemical Industries Ltd

    Find Probenecid bulk offered by Assia Chemical Industries Ltd

    Find Ramelteon bulk offered by Assia Chemical Industries Ltd

    Find Rasagiline Mesylate bulk offered by Assia Chemical Industries Ltd

    Find Risedronate Sodium bulk offered by Assia Chemical Industries Ltd

    Find Risperidone bulk offered by Assia Chemical Industries Ltd

    Find Rivaroxaban bulk offered by Assia Chemical Industries Ltd

    Find Rosuvastatin Calcium bulk offered by Assia Chemical Industries Ltd

    Find Sertraline Hydrochloride bulk offered by Assia Chemical Industries Ltd

    Find Tadalafil bulk offered by Assia Chemical Industries Ltd

    Find Terazosin HCl bulk offered by Assia Chemical Industries Ltd

    Find Tigecycline bulk offered by Assia Chemical Industries Ltd

    Find Tirzepatide bulk offered by Assia Chemical Industries Ltd

    Find Trazodone Hydrochloride bulk offered by Assia Chemical Industries Ltd

    Find Valacyclovir Hydrochloride bulk offered by Assia Chemical Industries Ltd

    Find Venlafaxine Hydrochloride bulk offered by Assia Chemical Industries Ltd

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search